For press inquiries click here to contact us.
GenapSys
GenapSys raises $75M to bring its tabletop DNA sequencer to Asia amid coronavirus outbreak
Element Biosciences
Ex-Illumina director’s rival startup Element raises $80M, hiring 100 people
Venatorx Pharmaceuticals, Inc.
Malvern drugmaker is hopeful where others struggle: Fighting deadly ‘superbugs’
GenapSys
Biotech With iPad-Sized Gene Sequencer Gets Foresite-Led Funding
Turning Point Therapeutics
How Turning Point Therapeutics became a 2019 IPO standout
Lyell Immunopharma
Exclusive: GSK’s Hal Barron allies with Rick Klausner’s $600M cell therapy startup, looking to break new ground blitzing solid tumors
insitro
Coursera Cofounder Daphne Koller Melds AI And Biology In Drug Startup Insitro
Aimmune Therapeutics, Inc.
It’s not perfect, but it’s a good start: FDA panelists largely endorse Aimmune’s peanut allergy therapy
10x Genomics
10x Genomics’ IPO rockets past a $390M raise
Please see important disclaimers in the Terms section.
